Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis

Journal of Investigative Dermatology

Volumn 135, Issue 1, 2015, Pages 151-159

  Inkeles, Megan S ^a   Scumpia, Philip O ^a   Swindell, William R ^b   Lopez, David ^a   Teles, Rosane M B ^a   Graeber, Thomas G ^c   Meller, Stephan ^d   Homey, Bernhard ^d   Elder, James T ^b,e   Gilliet, Michel ^f   Modlin, Robert L ^a   Pellegrini, Matteo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; TRANSCRIPTOME;

ARTICLE; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; BURN; CLINICAL FEATURE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IRRITANT DERMATITIS; LEPROSY; MICROARRAY ANALYSIS; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PSORIASIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SKIN ALLERGY; SKIN CARCINOMA; SKIN DISEASE; SKIN INJURY; STEVENS JOHNSON SYNDROME; SURGICAL WOUND; ULCUS MOLLE; BIOLOGICAL MODEL; CLUSTER ANALYSIS; GENETICS; IMMUNOLOGY; PREDICTIVE VALUE; SKIN DISEASES;

CLUSTER ANALYSIS; HUMANS; INTERFERON-BETA; INTERFERON-GAMMA; MICROARRAY ANALYSIS; MODELS, GENETIC; PREDICTIVE VALUE OF TESTS; SKIN DISEASES; TRANSCRIPTOME;

EID: 84925970190     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.352     Document Type: Article

References (37)

1. Alazemi S, Campos MA (2006) Interferon-induced sarcoidosis. Int J Clin Pract 60:201-11
2. Beer WE, Smith AE, Kassab JY et al. (1992) Concomitance of psoriasis and atopic dermatitis. Dermatology 184:265-70
3. Breiman L (2001) Random forests. Mach Learn 45:5-32
4. Cai Y, Fleming C, Yan J (2012) New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 9:302-9
5. Chaussabel D, Quinn C, Shen J et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29:150-64
6. Chung WH, Hung SI, Yang JY et al. (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343-50
7. Clark RA, Kupper TS (2007) IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 109:194-202
8. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-10
9. Eyerich S, Onken AT, Weidinger S et al. (2011) Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 365:231-8
10. Fujimoto W, Nakanishi G, Arata J et al. (1997) Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions. J Invest Dermatol 108:200-4
11. Grassegger A, Höpfl R (2004) Significance of the cytokine interferon gamma in clinical dermatology. Clin Exp Dermatol 29:584-8
12. Grewe M, Gyufko K, Schöpf E et al. (1994) Lesional expression of interferongamma in atopic eczema. Lancet 343:25-6
13. Grewe M, Walther S, Gyufko K et al. (1995) Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105:407-10
14. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94: 870-6
15. Hanafusa T, Matsui S, Murota H et al. (2013) Increased frequency of skininfiltrating FoxP3 regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma. Clin Exp Immunol 172:507-12
16. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-6
17. Huang dW, Sherman BT, Lempicki RA (2009a) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13
18. Huang dW, Sherman BT, Lempicki RA (2009b) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
19. Illing PT, Vivian JP, Purcell AW et al. (2013) Human leukocyte antigenassociated drug hypersensitivity. Curr Opin Immunol 25:81-9
20. Kamsteeg M, Jansen PA, van Vlijmen-Willems IM et al. (2010) Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis. Br J Dermatol 162:568-78
21. Li B, Tsoi LC, Swindell WR et al. (2014) Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol 134:1828-38
22. McCall MN, Bolstad BM, Irizarry RA (2010) Frozen robust multiarray analysis (fRMA). Biostatistics 11:242-53
23. Mutch DM, Berger A, Mansourian R et al. (2002) The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics 3:17
24. Nassif A, Bensussan A, Boumsell L et al. (2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114:1209-15
25. O'Regan GM, Sandilands A, McLean WH et al. (2008) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 122:689-93
26. Skurkovich B, Skurkovich S (2006) Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases. Ernst Schering Res Found Workshop 1-27
27. Suárez-Fariñas M, Li K, Fuentes-Duculan J et al. (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552-64
28. Suárez-Fariñas M, Tintle SJ, Shemer A et al. (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127: 954-64.e1-4
29. Swindell WR, Johnston A, Voorhees JJ et al. (2013) Dissecting the psoriasis transcriptome: inflammatory-and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics 14:527
30. Swindell WR, Xing X, Stuart PE et al. (2012) Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis. PLoS ONE 7:e3459
31. Teles RM, Graeber TG, Krutzik SR et al. (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339:1448-53
32. Tu Y, Stolovitzky G, Klein U (2002) Quantitative noise analysis for gene expression microarray experiments. Proc Natl Acad Sci USA 99:14031-6
33. Waddell SJ, Popper SJ, Rubins KH et al. (2010) Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS ONE 5:e9753
34. Wong D, Kea B, Pesich R et al. (2012) Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. PLoS ONE 7:e2916
35. Yamamura M, Uyemura K, Deans RJ et al. (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277-9
36. Yamashita T, Abbade LP, Marques ME et al. (2012) Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update. An Bras Dermatol 87:817-28
37. Yao Y, Richman L, Morehouse C et al. (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS ONE 3:e2737